Hyperthermia-embolization-immunotherapy: a potent trio in advancing cancer treatment.
cancer
immunotherapy
liquid metal microspheres
magnetic hyperthermia
transcatheter arterial embolization
Journal
Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
received:
10
09
2023
revised:
09
10
2023
accepted:
10
10
2023
medline:
13
11
2023
pubmed:
21
10
2023
entrez:
20
10
2023
Statut:
ppublish
Résumé
Yang et al. recently demonstrated the high potential of liquid metal microspheres (LM MSs) in cancer therapy. By amplifying the effects of magnetic hyperthermia and embolization, LM MSs not only target primary tumors, but also potentiate immune defenses. This dual-action approach effectively curtails distant tumor growth, marking a pivotal advancement in cancer immunotherapy.
Identifiants
pubmed: 37863716
pii: S1471-4914(23)00238-1
doi: 10.1016/j.molmed.2023.10.003
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
976-978Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.